Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02574286||Active, not recruiting||Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher Disease||
||19||All||18 Years to 70 Years (Adult, Older Adult)||NCT02574286||SHP-GCB-402
|June 29, 2016||December 30, 2020||January 30, 2021||October 12, 2015||June 17, 2019||
|2||NCT00004488||Completed||Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease||
||82||All||18 Years to 50 Years (Adult)||NCT00004488||199/14269
|October 1998||September 2002||October 19, 1999||March 25, 2015||